Oracle Expands Life Sciences Data Intelligence With AI and RWD
ORLANDO, Fla. — September 23, 2026 Oracle announced expanded capabilities in Oracle Life Sciences Data Intelligence, combining real-world data,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ORLANDO, Fla. — September 23, 2026 Oracle announced expanded capabilities in Oracle Life Sciences Data Intelligence, combining real-world data,...
SALT LAKE CITY, Utah — September 15, 2026 PolarityBio announced that the U.S. Food and Drug Administration (FDA) has...
Cambridge, Massachusetts, USA, September 8, 2026 LabCentral has launched The Loop, a new program designed to help international biotech...
MONTREAL, Quebec, September 2, 2026 Pendopharm, a division of Pharmascience Inc., in collaboration with Ascendis Pharma A/S, announced that...
ISELIN, N.J., August 14, 2026 Outlook Therapeutics, Inc. is advancing preparations for the U.S. commercial launch of LYTENAVA™ (bevacizumab-vikg)...
CHICAGO, July 30, 2026 EVERSANA has been selected by Innovacell Inc. as its exclusive U.S. commercialization partner to support...
CRANFORD, N.J., March 31, 2026 Citius Oncology, Inc. has reported strong early momentum following the U.S. launch of its...
BOSTON, Feb. 2, 2026 — Red Nucleus, a global strategic partner to pharmaceutical and biotechnology companies, announced a definitive...
